Skip to content

Carnosine

A naturally occurring dipeptide concentrated in muscle and brain tissue, studied for anti-aging, cognitive support, and exercise performance.

ModerateWell-Studied Beginner-Friendly

What is Carnosine?

Carnosine (beta-alanyl-L-histidine) is a naturally occurring dipeptide found at high concentrations in skeletal muscle, heart, and brain tissue. It acts as a pH buffer during exercise, an antioxidant, an anti-glycation agent, and a metal chelator. Carnosine levels decline with age, which has driven interest in supplementation for longevity and cognitive support. It is one of the most studied dipeptides in human biology, with a strong safety profile from decades of supplement use.

Why People Talk About It

Anti-aging and longevity (anti-glycation)

Moderate

Cognitive support and neuroprotection

Moderate

Exercise performance (pH buffering)

Moderate

Blood sugar and metabolic health

Emerging

Skin anti-aging (anti-glycation of collagen)

Emerging

How It Works

Carnosine protects your cells in multiple ways: it buffers acid buildup during exercise (preventing fatigue), blocks sugar molecules from damaging proteins (a key aging process called glycation), neutralizes free radicals, and chelates excess metals that can cause cellular damage.

Common Questions

Safety Information

Important Safety Notes

Common Side Effects

Generally very well-toleratedRare: mild tingling or paresthesia (more common with beta-alanine)Occasional mild GI discomfort

Cautions

  • Very safe even at high doses in studies
  • Those with histidine metabolism disorders should consult a physician
  • May interact with certain diabetes medications (additive blood sugar lowering)

What We Don't Know

Oral carnosine is rapidly broken down by serum carnosinase, which limits bioavailability. Strategies to improve this (sustained-release formulations, carnosinase-resistant analogs) are under investigation.

Published Research

12 studies

Neuroprotective effects of carnosine and homocarnosine: an emerging role in neurodegenerative diseases

ReviewPMID: 31142170

Carnosine supplementation reduces the fasting plasma glucose level and improves glycemic control in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

RCT showing carnosine supplementation (2g/day for 12 weeks) significantly reduced fasting glucose and HbA1c in type 2 diabetes patients.

Randomized Controlled TrialPMID: 29164838

Carnosine and related peptides: Therapeutic potential in age-related disorders

Review of carnosine's anti-glycation and anti-aging properties, including evidence for protection against AGE-mediated tissue damage in diabetic complications.

ReviewPMID: 28011264

A randomized, double-blind, placebo-controlled trial of carnosine supplementation for cognitive function in older adults

RCT in older adults showing carnosine supplementation improved verbal episodic memory and reduced fatigue.

Randomized Controlled TrialPMID: 27452978

International society of sports nutrition position stand: Beta-Alanine

Comprehensive position paper confirming beta-alanine (carnosine precursor) supplementation improves exercise capacity, particularly in 1-10 minute high-intensity efforts.

ReviewPMID: 26175657

Role of carnosine in preventing AGE-related pathologies

ReviewPMID: 25832340

Carnosine and anserine homeostasis in skeletal muscle and heart is controlled by beta-alanine transamination

PreclinicalPMID: 24760587

A randomised, double-blind, placebo-controlled clinical trial of a product derived from Barbary-fig fruit (Opuntia ficus-indica) combined with L-carnosine in preventing cognitive decline in the elderly

Randomized Controlled TrialPMID: 24321175

L-carnosine supplementation in children with autism spectrum disorders: a double-blind, randomized, placebo-controlled pilot study

Randomized Controlled TrialPMID: 23392822

Histidine-containing dipeptides as endogenous regulators of the activity of myeloperoxidase

PreclinicalPMID: 22804811

The effect of beta-alanine supplementation on neuromuscular fatigue in elderly (55-92 Years): a double-blind randomized study

Randomized Controlled TrialPMID: 19276843

Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1

Clinical TrialPMID: 15616024

Related Peptides

Quick Facts

Class
Endogenous Dipeptide
Evidence
Moderate
Safety
Well-Studied
Updated
Apr 2026
Citations
12PubMed

Also known as

L-CarnosineBeta-Alanyl-L-Histidine

Tags

LongevityAnti-AgingCognitiveExerciseAntioxidant

Evidence Score

Overall Confidence65%

Clinical Trials

View Clinical Trials

Links to ClinicalTrials.gov for reference. Listing does not imply endorsement.